K Number
K100180
Device Name
SURGIQUEST ANCHORPORT SIL KIT
Manufacturer
Date Cleared
2010-05-05

(104 days)

Product Code
Regulation Number
876.1500
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The AnchorPort® SIL Kit has applications in abdominal minimally invasive surgical procedures to include single skin incision applications and specifically where the surgeon anticipates using at least three 5mm cannula ports to establish a path of entry for operating endoscopic instruments.
Device Description
The subject is a surgical trocar and cannula kit is composed of biosafe materials. The device incorporates an expandable elastomer sheath, which serves to hold the cannula vertically in place during endoscopic surgery. The device is used to create and maintain a port of entry during endoscopic surgery. It is fully disposable and is intended for single use only.
More Information

Not Found

No
The device description and performance studies focus on the mechanical and physical properties of a surgical trocar and cannula kit, with no mention of AI or ML.

No
The device is a surgical trocar and cannula kit used to create and maintain a port of entry during endoscopic surgery, which is an accessory to surgery, not a therapeutic device.

No
Explanation: The device is a surgical trocar and cannula kit used to create and maintain a port of entry during endoscopic surgery, which is a therapeutic rather than diagnostic function.

No

The device description explicitly states it is a "surgical trocar and cannula kit is composed of biosafe materials" and describes physical components like an "expandable elastomer sheath." The performance studies also detail benchtop and animal testing of physical properties and performance, indicating it is a hardware device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states the device is for "abdominal minimally invasive surgical procedures" to establish a "path of entry for operating endoscopic instruments." This describes a surgical tool used in vivo (within a living organism) during a procedure.
  • Device Description: The description confirms it's a "surgical trocar and cannula kit" used to "create and maintain a port of entry during endoscopic surgery." This further reinforces its use as a surgical instrument.
  • Lack of IVD Characteristics: An IVD is a medical device used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. The provided information does not mention any testing of biological samples or diagnostic purposes.
  • Performance Studies: The performance studies described are focused on the mechanical and functional aspects of the device during surgery (leak rate, insertion/removal, fixation, etc.) and its performance in animal models during a surgical procedure. These are not studies related to the accuracy or performance of a diagnostic test.

Therefore, the AnchorPort® SIL Kit is a surgical device, not an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

The AnchorPort® SIL Kit has applications in abdominal minimally invasive surgical procedures to include single skin incision applications and specifically where the surgeon anticipates using at least three 5mm cannula ports to establish a path of entry for operating endoscopic instruments.

The AnchorPort® SIL Kit has applications in abdominal minimally invasive surgical procedures and specifically where the surgeon will make a single skin incision in order to facilitate the use of multiple trocars to establish a port of entry for operating endoscopic instruments.

Product codes

GCJ

Device Description

The subject is a surgical trocar and cannula kit is composed of biosafe materials. The device incorporates an expandable elastomer sheath, which serves to hold the cannula vertically in place during endoscopic surgery. The device is used to create and maintain a port of entry during endoscopic surgery. It is fully disposable and is intended for single use only.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

abdominal

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Nonclinical test protocols were designed in order to test the critical performance and safety features of the device. The following bench top tests were performed in order to prove substantial equivalence and test reports are included in the filing:

Bench Data:

  • Leak rate without trocars in place, after multiple trocars . in place and after vigorous manipulation of trocars.
  • . Device insertion and removal evaluation
  • Minimum size of skin incision .
  • . Device fixation
  • . Rigidity / Flexibility
  • Size / Dimension ●
  • Sealing Instrument for maintaining insufflation .
  • Deployment method .

In vitro bench top testing has confirmed that the device is substantially equivalent in all manner of operation to the predicate devices sighted in this filing. The tests performed and submitted are those tests sighted in the above section and include method of deployment, fixation, insertion and removal forces, and maintenance of pneumoperitoneum during ordinary use and severe manipulation and incision size. In each case, the device was at least as safe and effective as the predicate.

In vivo animal studies were performed, including a porcine cholecysectomy, by surgeons familiar with the predicate device(s). The in vivo testing with the AnchorPort® device demonstrates that the AnchorPort® is safe and effective. In each aspects of device performance the AnchorPort® performed as well as or better than the predicate(s) in the aspects of insertion and removal forces, anchoring and fixation and maintenance of pneumoperitoneum. The clinical outcome of the porcine cholecysectomy was a success with no adverse effects or complications.

Animal Data:

  • Ease of port insertion, suturing and time to insert .
  • . Ease of insertion and withdrawal
  • . Ability to maintain pneumoperitoneum
  • Ability to manipulate instruments for laparoscopic . surgery
  • . Ability to conduct a typical laparoscopic procedure: cholecystectomy
  • . Ability of anchoring plate to hold the ports in position

In conclusion, extensive in vivo (animal) testing and in vitro (bench top) testing demonstrates conclusively that the device is substantially equivalent. The device performance was validated using robust engineering test methods and living tissue models and performed at least as safely and effectively as the legally marketed devices sighted in this 510(k) submission.

Key Metrics

Not Found

Predicate Device(s)

K 063859, K090275, K082619, K903419, K032676

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

0

100180 PAGE 1 of (3)

..

SurgiQuest, Inc. 510(K) Notification SurgiQuest AnchorPort® Optical Trocar & Cannula SIL Kit

510(k) SUMMARY OF SAFETY & EFFECTIVENESS

| SUBMITTER | SurgiQuest, Inc.
12 Cascade Boulevard, Suite 2B
Orange, CT 06477
Phone: 203.799.2400 | MAY - 5 2016 |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|
| CONTACT PERSON | Kourosh Azarbarzin
Founder & C.E.O. - SurgiQuest, Inc. | |
| DATE PREPARED | January 8, 2010 | |
| CLASSIFICATION | Laparoscopic trocar, GCJ
Class: II | |
| COMMON NAME | Disposable Endoscopic Optical Trocar & Cannula Kit | |
| PROPRIETARY NAME | SurgiQuest AnchorPort® SIL Kit | |
| PREDICATE DEVICE | SurgiQuest Elastomeric Optical trocar & Cannula
SurgiQuest, Inc. (Orange, CT)
K 063859 | |
| | GelPOINT System
Applied Medical (Rancho Santa Margarita, CA)
K090275 | |
| | SILSTM Port
Covidien LP (North Haven, CT)
K082619 | |
| | Surgiport™ Blunt Tip Trocar
U.S. Surgical Corp. (Norwalk, CT)
K903419 | |
| | EndoPath III™ Trocar System
Ethicon Endo-Surgery, Inc. (Cincinnati, OH)
K032676 | |
| DEVICE DESCRIPTION | The subject is a surgical trocar and cannula kit is composed of
biosafe materials. The device incorporates an expandable
elastomer sheath, which serves to hold the cannula vertically in
place during endoscopic surgery. The device is used to create
and maintain a port of entry during endoscopic surgery. It is
fully disposable and is intended for single use only. | |

1

100180 Page 2 of (3)

SurgiQuest, Inc. 510(K) NOTIFICATION SurgiQuest AnchorPort® Optical Trocar & Cannula SIL Kit.

INDICATIONS

The AnchorPort® SIL Kit has applications in abdominal minimally invasive surgical procedures to include single skin incision applications and specifically where the surgeon anticipates using at least three 5mm cannula ports to establish a path of entry for operating endoscopic instruments.

NONCLINICAL TESTS SUBMITTED, REFERENCED OR RELIED UPON FOR A DETERMINATION OF SUBSTANTIAL EQUIVALENCE

Nonclinical test protocols were designed in order to test the critical performance and safety features of the device. The following bench top tests were performed in order to prove substantial equivalence and test reports are included in the filing:

Bench Data:

  • Leak rate without trocars in place, after multiple trocars . in place and after vigorous manipulation of trocars.
  • . Device insertion and removal evaluation
  • Minimum size of skin incision .
  • . Device fixation
  • . Rigidity / Flexibility
  • Size / Dimension ●
  • Sealing Instrument for maintaining insufflation .
  • Deployment method .

In vitro bench top testing has confirmed that the device is substantially equivalent in all manner of operation to the predicate devices sighted in this filing. The tests performed and submitted are those tests sighted in the above section and include method of deployment, fixation, insertion and removal forces, and maintenance of pneumoperitoneum during ordinary use and severe manipulation and incision size. In each case, the device was at least as safe and effective as the predicate.

In vivo animal studies were performed, including a porcine cholecysectomy, by surgeons familiar with the predicate device(s). The in vivo testing with the AnchorPort® device demonstrates that the AnchorPort® is safe and effective. In each aspects of device performance the AnchorPort® performed as well as or better than the predicate(s) in the aspects of insertion and removal forces, anchoring and fixation and maintenance of pneumoperitoneum. The clinical outcome of the porcine cholecysectomy was a success with no adverse effects or complications.

Animal Data:

  • Ease of port insertion, suturing and time to insert .
  • . Ease of insertion and withdrawal
  • . Ability to maintain pneumoperitoneum

CONCLUSIONS DRAWN FROM THE NONCLINICAL AND CLINICAL TESTS THAT DEMONSTRATE THAT THE DEVICE IS SAFE, AS EFFECTIVE AND PERFORMS AT LEAST AS SAFELY AND EFFECTIVELY AS THE PREDICATE(S)

2

100180 Page 3. (3)

SurgiQuest, Inc. 510(K) NOTIFICATION SurgiQuest AnchorPort® Optical Trocar & Cannula SIL Kit

  • Ability to manipulate instruments for laparoscopic . surgery
  • . Ability to conduct a typical laparoscopic procedure: cholecystectomy
  • . Ability of anchoring plate to hold the ports in position

In conclusion, extensive in vivo (animal) testing and in vitro (bench top) testing demonstrates conclusively that the device is substantially equivalent. The device performance was validated using robust engineering test methods and living tissue models and performed at least as safely and effectively as the legally marketed devices sighted in this 510(k) submission.

3

Image /page/3/Picture/0 description: The image shows the text "DEPARTMENT OF HEALTH & HUMAN SERVICES". The text is in all caps and is in a sans-serif font. The text is black and the background is white. The text is centered in the image.

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract image of an eagle.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

SurgiQuest, Inc. % Mr. Kourosh Azarbarzin C.E.O. 12 Cascade Boulevard, Suite 2B Orange, Connecticut 06477

Re: K100180

Trade/Device Name: SurgiQuest AnchorPort® Single Incision Laparoscopic Kit (SILK) Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: Class II Product Code: GCJ Dated: April 01, 2010 Received: April 02, 2010

MAY - 5 "010

Dear Mr. Azarbarzin:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

4

Page 2 - Mr. Kourosh Azarbarzin

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address,

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

for

Mark N. Melkerson
Director

Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

PAGE 1 of (1)

SURGIQUEST, INC. 510(K) Notification SurgiQuest AnchorPort® Optical Trocar & Cannula SH. Kit

STATEMENT FOR INDICATIONS FOR USE

510(k) Number:

K 100180

Device Name: SurgiQuest AnchorPort® Single Incision Laparoscopic Kit (SILK)

Indications for Use: The AnchorPort® SIL Kit has applications in abdominal minimally invasive surgical procedures and specifically where the surgeon will make a single skin incision in order to facilitate the use of multiple trocars to establish a port of entry for operating endoscopic instruments.

Prescription Use: Yes

DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation

Neil R. Dylan Forman

Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number K100180